EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Evaluating Alignment of Prader-Willi Syndrome with the Australian Newborn Bloodspot Screening Criteria

Mohammed A Alshawsh iD, Oshadi Tennakoon iD, Sheena Arora iD, Ronda F Greaves iD, Jeanie Cheong iD, Katrina Williams iD, David E Godler iD

Expert Reviews in Molecular Medicine · 2026 · 28

DOI: 10.1017/erm.2026.10080 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Expert Reviews in Molecular Medicine, online erschienen am 29.10.2026. Verfasst von Mohammed A Alshawsh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, VIC, Australia. Hauptthemen laut MEDLINE: Prader-Willi Syndrome, Neonatal Screening. Die Arbeit nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Financial Markets Foundation for Children, Medical Research Future Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prader-Willi syndrome (PWS) is a leading genetic cause of life-threatening obesity, presenting with hypotonia and feeding difficulties in infancy, progressing to hyperphagia, cognitive impairment and behavioural challenges from childhood. It is a rare imprinting disorder caused by gene silencing at the 15q11–q13 locus. Early detection through newborn bloodspot screening (NBS) could enable timely interventions such as growth hormone therapy, dietary management and behavioural support to improve health and developmental outcomes for the affected infants.

Methods

This review applies the Australian Newborn Bloodspot Screening National Policy Framework as a reference to evaluate the suitability of incorporating PWS into NBS programs. The review outlines benefits and challenges in relation to key criteria used by this Framework, including condition severity, early detection benefits and screening test reliability.

Results

Emerging screening technologies are recognised for their high sensitivity and specificity and could be integrated into existing NBS workflows using dried blood spots. However, several challenges outlined in this review need to be addressed, including the lack of cost-effectiveness data for population-wide PWS screening programs and the absence of a curative treatment for PWS.

Conclusion

Expanding NBS to include PWS has the potential to improve health and developmental outcomes through earlier diagnosis and timely interventions. Successful implementation will depend on addressing the remaining challenges.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prader-Willi SyndromeNeonatal ScreeningHumansInfant, NewbornAustraliaGenetic Testing

Stichwörter der Autor:innen

Australian decision-making criteriaDNA methylation testingPrader-Willi syndromechromosome 15 imprinting disordersnewborn bloodspot screening

Autor:innen und Institutionen

  • Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, VIC, Australia.
  • Department of Paediatrics, Monash University, Clayton, VIC, Australia.
  • Division of Genome Sciences and Cancer, The John Curtin School of Medical Research, The Australian National University, ACT, Australia.
  • Centre for Health Economics Research and Evaluation, University of Technology Sydney, Broadway, NSW, Australia.
  • Victorian Clinical Genetics Services,Murdoch Children's Research Institute, Parkville, VIC, Australia.
  • Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia.

ORCID-Profile: Mohammed A Alshawsh, Oshadi Tennakoon, Sheena Arora, Ronda F Greaves, Jeanie Cheong, Katrina Williams, David E Godler

Förderung

  • National Health and Medical Research Council
  • Financial Markets Foundation for Children
  • Medical Research Future Fund

Zitieren

APA

Alshawsh, M. A., Tennakoon, O., Arora, S., Greaves, R. F., Cheong, J., Williams, K., & Godler, D. E. (2026). Evaluating Alignment of Prader-Willi Syndrome with the Australian Newborn Bloodspot Screening Criteria. Expert Reviews in Molecular Medicine, 28. https://doi.org/10.1017/erm.2026.10080

Vancouver

Alshawsh MA, Tennakoon O, Arora S, Greaves RF, Cheong J, Williams K, et al. Evaluating Alignment of Prader-Willi Syndrome with the Australian Newborn Bloodspot Screening Criteria. Expert Reviews in Molecular Medicine. 2026;28. doi:10.1017/erm.2026.10080

BibTeX
@article{Alshawsh2026,
  author = {Alshawsh, Mohammed A and Tennakoon, Oshadi and Arora, Sheena and Greaves, Ronda F and Cheong, Jeanie and Williams, Katrina and Godler, David E},
  title = {Evaluating Alignment of Prader-Willi Syndrome with the Australian Newborn Bloodspot Screening Criteria},
  journal = {Expert Reviews in Molecular Medicine},
  year = {2026},
  volume = {28},
  doi = {10.1017/erm.2026.10080}
}
Kostenlos starten →